Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis

Xiu Feng Wang, Qian Mei Zhou, Yi Yu Lu, Hui Zhang, Shuang Huang, Shi Bing Su

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Introduction: Radix Glycyrrhiza has been used in China for thousand years to treat cancer. However, focus on its tumor-suppressing mechanism has been concentrated on its effect on tumor cell growth and apoptosis.Objectives: With the aid of a panel of human breast cancer cell lines, we reveal that glycyrrhetinic acid (GA), a major component of Radix Glycyrrhiza, is actually a significantly more potent agent to suppress invasion than cell survival.Results: GA effectively inhibits breast cancer cell MMP-2/MMP-9 expression; GA-induced reduction in the MMP-2/9 expression is apparently mediated by GA's ability to specifically inhibit the p38 MAPK activity and its downstream AP1 activation. Moreover, we show that GA down regulates the levels of Fra-1 and c-Jun, two main components of AP1 transcription complex in invasive breast cancer cells and that AP1-specific inhibitor abrogates breast cancer cell invasion. These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of breast cancer cell invasion. Finally, we demonstrate that GA effectively suppresses breast tumor outgrowth and pulmonary metastasis without causing animal weight loss or eliciting liver/kidney toxicity to the recipient animals.Conclusion: This study indicates that GA represents a good candidate compound for the potential development of therapeutic drug.

Original languageEnglish (US)
Pages (from-to)577-587
Number of pages11
JournalExpert Opinion on Therapeutic Targets
Volume19
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Glycyrrhetinic Acid
p38 Mitogen-Activated Protein Kinases
Breast Neoplasms
Neoplasm Metastasis
Cells
Matrix Metalloproteinases
Glycyrrhiza
Tumors
Animals
Neoplasms
Cell growth
Transcription
Liver
Toxicity
Weight Loss
China
Cell Survival
Down-Regulation
Chemical activation
Apoptosis

Keywords

  • Breast cancer
  • Glycyrrhetinic acid
  • Invasion
  • MMP
  • P38 MAPK

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis. / Wang, Xiu Feng; Zhou, Qian Mei; Lu, Yi Yu; Zhang, Hui; Huang, Shuang; Su, Shi Bing.

In: Expert Opinion on Therapeutic Targets, Vol. 19, No. 5, 01.05.2015, p. 577-587.

Research output: Contribution to journalArticle

Wang, Xiu Feng ; Zhou, Qian Mei ; Lu, Yi Yu ; Zhang, Hui ; Huang, Shuang ; Su, Shi Bing. / Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis. In: Expert Opinion on Therapeutic Targets. 2015 ; Vol. 19, No. 5. pp. 577-587.
@article{2e48e26ae39b44ceb18648dd7ddc5cd5,
title = "Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis",
abstract = "Introduction: Radix Glycyrrhiza has been used in China for thousand years to treat cancer. However, focus on its tumor-suppressing mechanism has been concentrated on its effect on tumor cell growth and apoptosis.Objectives: With the aid of a panel of human breast cancer cell lines, we reveal that glycyrrhetinic acid (GA), a major component of Radix Glycyrrhiza, is actually a significantly more potent agent to suppress invasion than cell survival.Results: GA effectively inhibits breast cancer cell MMP-2/MMP-9 expression; GA-induced reduction in the MMP-2/9 expression is apparently mediated by GA's ability to specifically inhibit the p38 MAPK activity and its downstream AP1 activation. Moreover, we show that GA down regulates the levels of Fra-1 and c-Jun, two main components of AP1 transcription complex in invasive breast cancer cells and that AP1-specific inhibitor abrogates breast cancer cell invasion. These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of breast cancer cell invasion. Finally, we demonstrate that GA effectively suppresses breast tumor outgrowth and pulmonary metastasis without causing animal weight loss or eliciting liver/kidney toxicity to the recipient animals.Conclusion: This study indicates that GA represents a good candidate compound for the potential development of therapeutic drug.",
keywords = "Breast cancer, Glycyrrhetinic acid, Invasion, MMP, P38 MAPK",
author = "Wang, {Xiu Feng} and Zhou, {Qian Mei} and Lu, {Yi Yu} and Hui Zhang and Shuang Huang and Su, {Shi Bing}",
year = "2015",
month = "5",
day = "1",
doi = "10.1517/14728222.2015.1012156",
language = "English (US)",
volume = "19",
pages = "577--587",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis

AU - Wang, Xiu Feng

AU - Zhou, Qian Mei

AU - Lu, Yi Yu

AU - Zhang, Hui

AU - Huang, Shuang

AU - Su, Shi Bing

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Introduction: Radix Glycyrrhiza has been used in China for thousand years to treat cancer. However, focus on its tumor-suppressing mechanism has been concentrated on its effect on tumor cell growth and apoptosis.Objectives: With the aid of a panel of human breast cancer cell lines, we reveal that glycyrrhetinic acid (GA), a major component of Radix Glycyrrhiza, is actually a significantly more potent agent to suppress invasion than cell survival.Results: GA effectively inhibits breast cancer cell MMP-2/MMP-9 expression; GA-induced reduction in the MMP-2/9 expression is apparently mediated by GA's ability to specifically inhibit the p38 MAPK activity and its downstream AP1 activation. Moreover, we show that GA down regulates the levels of Fra-1 and c-Jun, two main components of AP1 transcription complex in invasive breast cancer cells and that AP1-specific inhibitor abrogates breast cancer cell invasion. These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of breast cancer cell invasion. Finally, we demonstrate that GA effectively suppresses breast tumor outgrowth and pulmonary metastasis without causing animal weight loss or eliciting liver/kidney toxicity to the recipient animals.Conclusion: This study indicates that GA represents a good candidate compound for the potential development of therapeutic drug.

AB - Introduction: Radix Glycyrrhiza has been used in China for thousand years to treat cancer. However, focus on its tumor-suppressing mechanism has been concentrated on its effect on tumor cell growth and apoptosis.Objectives: With the aid of a panel of human breast cancer cell lines, we reveal that glycyrrhetinic acid (GA), a major component of Radix Glycyrrhiza, is actually a significantly more potent agent to suppress invasion than cell survival.Results: GA effectively inhibits breast cancer cell MMP-2/MMP-9 expression; GA-induced reduction in the MMP-2/9 expression is apparently mediated by GA's ability to specifically inhibit the p38 MAPK activity and its downstream AP1 activation. Moreover, we show that GA down regulates the levels of Fra-1 and c-Jun, two main components of AP1 transcription complex in invasive breast cancer cells and that AP1-specific inhibitor abrogates breast cancer cell invasion. These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of breast cancer cell invasion. Finally, we demonstrate that GA effectively suppresses breast tumor outgrowth and pulmonary metastasis without causing animal weight loss or eliciting liver/kidney toxicity to the recipient animals.Conclusion: This study indicates that GA represents a good candidate compound for the potential development of therapeutic drug.

KW - Breast cancer

KW - Glycyrrhetinic acid

KW - Invasion

KW - MMP

KW - P38 MAPK

UR - http://www.scopus.com/inward/record.url?scp=84928495710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928495710&partnerID=8YFLogxK

U2 - 10.1517/14728222.2015.1012156

DO - 10.1517/14728222.2015.1012156

M3 - Article

VL - 19

SP - 577

EP - 587

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 5

ER -